Table 2:
Comparisons of demographic, cognitive, functional and clinical measures by patient diagnostic group at baseline
| SZ Patients | BD Patients | Statistic (df) | p value | |||
|---|---|---|---|---|---|---|
| Mean (SD) | N | Mean (SD) | N | |||
| Age | 22.67 (3.96) | 24 | 23.4 (3.61) | 30 | t = −0.71 (52) | 0.4805 |
| Male (counts and %) | 16 (66.67%) | 24 | 17 (56.67%) | 30 | χ 2 = 0.1346 | 0.714 |
| Education | 14.33 (1.55) | 24 | 15.13 (1.74) | 30 | t = −1.76 (52) | 0.0838 |
| Full Scale IQ (FSIQ) | 116.49 (8.22) | 24 | 116.36 (7.01) | 30 | t = 0.062 (52) | 0.951 |
| Duration of Illness (yr) | 1.45 (1.35) | 24 | 1.17 (1.0) | 29 | t = 0.88 (51) | 0.38 |
| Age of Onset | 21.21 (4.05) | 24 | 22.21 (3.82) | 30 | t = −0.92 (52) | 0.36 |
| MATRICS Social Subscore | 50.14 (9.40) | 21 | 53.14 (10.68) | 29 | t = −1.028 (48) | 0.3091 |
| Composite neurocognition | 42.10 (8.22) | 21 | 46.19 (9.88) | 30 | t = −1.56 (49) | 0.1261 |
| MCAS total score | 42.83 (8.42) | 23 | 48.57 (4.23) | 30 | t = −3.24 (51) | 0.0021 |
| TASIT | 53 (5.70) | 14 | 55.71 (5.09) | 21 | t = −1.47 (33) | 0.1500 |
| UPSA total score | 74.87 (12.50) | 14 | 80.92 (11.03) | 21 | t = −1.51 (33) | 0.1410 |
| CPZ | 205.94 (201.73) | 21 | 154.38 (188.66) | 28 | t = 0.92 (47) | 0.3627 |
| PANSS Positive | 15.13 (6.41) | 23 | 12.03 (6.27) | 30 | t = 1.77 (51) | 0.0835 |
| PANSS Negative | 13.30 (4.51) | 23 | 11.37 (3.75) | 30 | t = 1.71 (51) | 0.0936 |
| PANSS General | 30.87 (5.47) | 23 | 27.07 (7.19) | 30 | t = 2.11 (51) | 0.0398 |
| PANSS Total | 59.30 (12.29) | 23 | 50.47 (14.53) | 30 | t = 2.34 (51) | 0.0231 |
Average baseline demographic, cognitive, and functional measures, represented by mean and standard deviation, were compared between SZ and BD patients. Bolded text represents significant differences between groups.